齐普罗夫洛克萨通过结合在外侧,距离触媒口袋的触媒口袋来抑制 ангиотензин I 转化酶 (ACE) 的活性
Kyle S Gregory1, Vinasha Ramasamy2, Edward D Sturrock2
1Department of Life Sciences, University of Bath, Claverton Down, Bath BA2 7AY, U.K.
ACS bio & med chem Au
|October 20, 2025
概括
齐普罗夫洛克萨通过与全位结合来抑制血管酶转化酶 (ACE) 活性,为开发改进的ACE抑制剂提供了一条新途径,其副作用比目前的治疗方法少.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
背景情况:
- 人体体内 ангиотензин I 转化酶 (ACE) 对心血管调节至关重要.
- ACE 抑制剂广泛用于高血压和心力衰竭,但由于非选择性抑制,具有副作用.
- 改善ACE抑制剂需要针对特定的域或全位.
研究的目的:
- 调查西普罗夫洛克萨作为潜在的ACE抑制剂.
- 为了确定普洛克萨与ACE相互作用的结合方式和结构基础.
- 探索西普罗夫洛克萨作为开发新型全性ACE抑制剂的支架.
主要方法:
- 酶抑制试验用于确定IC50和Ki值.
- 高分辨率的晶体结构确定ACE与西普罗夫洛克萨复合.
- 对结合部位和相互作用方式的分析.
主要成果:
- 齐普罗夫洛克萨证明了ACE (cACE) 的C域的强烈抑制,IC50为202.7μM,Ki为33.8μM.
- 晶体结构显示,西普罗洛克萨与活性部位不同的外细胞结合,这表明全抑制.
- 识别的结合模式为设计新的全抑制剂提供了结构基础.
结论:
- 齐普罗夫洛克萨是一种新型的ACE全抑制剂.
- 对普洛素结合的结构性见解可以指导改进的ACE抑制剂的开发,并可能减少副作用.
- 这一发现为心血管疾病开辟了新的治疗策略.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
Antihypertensive Drugs: Action of β1 Blockers
1.9K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.9K
Allosteric Proteins-ATCase
6.5K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.5K


